MET expression
|
Gastroesophageal Junction Adenocarcinoma
|
MET expression
|
Gastroesophageal Junction Adenocarcinoma
|
AMG 102 Resistant: B - Late Trials
|
AMG 102 Resistant: B - Late Trials
|
MET expression
|
Gastric Adenocarcinoma
|
MET expression
|
Gastric Adenocarcinoma
|
AMG 102 Resistant: B - Late Trials
|
AMG 102 Resistant: B - Late Trials
|
MET expression
|
HCC
|
MET expression
|
HCC
|
sorafenib Sensitive: D – Preclinical
|
sorafenib Sensitive: D – Preclinical
|
MET expression
|
NSCLC
|
MET expression
|
NSCLC
|
entrectinib Resistant: D – Preclinical
|
entrectinib Resistant: D – Preclinical
|